September 2011 Issue

Financier Worldwide Magazine

Click cover to download

(Subscriber-only password access)


Not a subscriber?

Click here to join the FREE mailing list and receive password access

To read an article, download the full issue by clicking the cover above.



Energy deals accelerate



India’s new merger control rules

Borders Inc goes into liquidation

US IPO activity back to pre-recession levels

Accounting fraud in US-listed Chinese companies



Effective dispute resolution

THE PANELLISTS: Tim Portwood, Bredin Prat; Peter Henein, Cassels Brock & Blackwell LLP; Mark Friedman, Debevoise & Plimpton LLP; John L. Oberdorfer, Patton Boggs LLP; Brenda Horrigan, Salans LLP; Lee A. Rosengard, Stradley Ronon Stevens & Young, LLP; and Marco Tulio Venegas, Von Wobeser y Sierra, S.C.



Biotech & pharmaceutical sector


FORUM: Outlook for the biotech & pharma industry

THE PANELLISTS: Alan Eisenberg, BIO; David H. Donabedian, GlaxoSmithKline; Diane M. Frenier, Reed Smith; and Clive Thorne, Reynolds Porter Chamberlain.


Promise or peril for biotech?

Alan Eisenberg, Biotechnology Industry Organization (BIO)


IP due diligence: key areas of analysis in biotech and pharma transactions

Robert H. Fischer and Jonathan Berschadsky, Fitzpatrick, Cello, Harper & Scinto


The US FDA implements a new pathway for biosimilar and interchangeable biologic products

Daniel A. Kracov, Arnold & Porter LLP


Are genes patentable?

Simon O’Brien, D Young & Co LLP


Navigating China’s pharmaceutical industry

Pang Zhang-Whitaker, Cozen O’Connor



mergers & acquisitions

M&A volume in H1 2011 up 9 percent year on year

Value of mining M&A doubles in H1 2011


private equity & venture capital 

July sees jump in mega buyouts

US venture investment levels dip in Q2 2011


bankruptcy & corporate restructuring

Dynegy moves towards recovery

AIG sues Bank of America for $10bn



Banking & finance

What every finance professional and CFO needs to know now and for 2012

Theodore (Ted) L. Koenig, Monroe Capital LLC


The ‘risky’ risk-free rate: does the downgrade of US sovereign debt change commonly-used valuation approaches?

Cindy Ma, Tim Smith and Andrew MacNamara, Houlihan Lokey


Multinational ‘living wills’: the challenges of cross-jurisdictional contingency planning

James Falconer, Skadden, Arps, Slate, Meagher and Flom (UK) LLP


Asset tracing

EAPOs – a future weapon in the asset recovery arsenal?

Rhys Novak and Laura Simmonds, Speechly Bircham LLP


Asset tracing and recovery in the Channel Islands

Christian Hay, Kathryn Purkis and Sam Dingle, Collas Crill


Money laundering through correspondent bank accounts

Eric L. Lewis, Baach Robinson & Lewis PLLC



Capital markets

The decline of the US capital markets

Blake Hornick and Michael Dunn, Seyfarth Shaw LLP


New forms of risk in US capital markets

Aviv Pichhadze, York University


The return of offshore domiciled SPACs

Simon Schilder and Richard Daggett, Ogier


Intellectual property

Protecting your brand in business: a win for brand owners?

Carollanne Lindley and Kristina Cornish, Kilburn & Strode LLP


Freedom-to-operate: background and basics

Barry Franks, Brann AB


Is there hidden value in my company’s patent portfolio?

Brian Frizzell and Joshua Becker, Charles River Associates (CRA)


Arnold & Porter LLP

Baach Robinson & Lewis PLLC

Biotechnology Industry Organization (BIO)

Brann AB

Bredin Prat

Cassels Brock & Blackwell LLP

Charles River Associates (CRA)

Collas Crill

Cozen O’Connor

D Young & Co LLP

Debevoise & Plimpton LLP

Fitzpatrick, Cello, Harper & Scinto


Houlihan Lokey

Kilburn & Strode LLP

Monroe Capital LLC


Patton Boggs LLP

Reed Smith

Reynolds Porter Chamberlain

Salans LLP

Seyfarth Shaw LLP

Skadden, Arps, Slate, Meagher and Flom (UK) LLP

Speechly Bircham LLP

Stradley Ronon Stevens & Young, LLP

Von Wobeser y Sierra, S.C.

York University

©2001-2019 Financier Worldwide Ltd. All rights reserved.